Fasken is delighted to announce that Christine Elliott, former Ontario Minister of Health and Deputy Premier, and Counsel with the firm’s Health Law Group in Toronto, will be a featured guest at Canada’s Medtech Conference 2025, presented by Medtech Canada. Timothy Squire, Fasken Partner and Co-Leader of the firm's Life Sciences Industry Practice Group, will also participate in the event, which will take place on May 8, 2025, at The Vue in Toronto.
Canada’s Medtech Conference is the premier event for information exchange, collaboration, and education within the medical technology sector. This must-attend event brings together key stakeholders from across the industry, including high-profile health system leaders, government representatives, and influential thought leaders.
In addition to Christine Elliott’s insightful remarks, participants will also have the opportunity to hear conferences, including:
• The Future of Healthcare and What It Means for Medtech
• Engaging with Public Policy to Deliver a Paradigm Shift in Purchasing Policy and Practice
• The Economic Future of Canada and What it Means for the Medical Technology Sector
Attendees will gain valuable insights and forge connections that will help shape the future of medical technology in Canada and beyond.
Event: Canada’s Medtech Conference 2025, presented by Medtech Canada
When: May 8, 2025, 9:00 a.m.—7:00 p.m.
Where: The Vue, 195 Galaxy Blvd, Toronto, Ontario
For more information and to register, click here.
About Fasken's Life Sciences Team
Fasken’s team provides comprehensive support to life sciences clients throughout their lifecycle. Whether you’re a biotech startup, entering clinical trials, scaling up, expanding to new markets or exploring exit strategies, our team speaks your language.
We know the unique challenges biotech and pharma companies face in securing and enforcing your patent portfolio, bringing a product to market, complying with Canada’s regulations, or raising funds across a competitive landscape. We have knowledgeable practitioners with advanced degrees in pharmaceutical sciences, clinical pharmacology, toxicology, and genetics. We know the sector.
Fasken lawyers and agents collaborate with our clients to provide advice tailored to your needs including marketing and product labelling, IP drafting and enforcement, competition, tax, litigation, contracts and agreements and a full range of corporate services from financings to M&A. Navigate complex challenges and bring your products to market in Canada with a team dedicated to your success. With a strong legal network in 47 countries, we also continue to be at the forefront of life science advancement and interests globally.
Fasken is ranked Band 1 by Chambers for life sciences and is the most recognized Firm on The Globe & Mail’s list of Canada’s Best Law Firms 2025, including in every category of corporate law and in healthcare & life sciences and intellectual property.
Find out more about Fasken’s Life Sciences team at fasken.com.
